Recent advancements in cardiac regeneration research have led to innovative therapies that aim to enhance the healing process after cardiac injury. Preclinical studies and early-phase clinical trials are exploring the safety and efficacy of various regenerative approaches. These may involve the transplantation of stem cells, the use of growth factors to stimulate tissue repair, or the development of bioengineered cardiac patches that can be implanted to replace damaged tissue. The ultimate goal is to develop interventions that not only repair the structural damage caused by heart diseases but also restore optimal cardiac function. While challenges and complexities remain, the potential for cardiac regeneration to transform the landscape of cardiovascular medicine is driving continued research and collaboration among scientists, clinicians, and experts in regenerative medicine.
Title : Pharmacological advancement in pulmonary arterial hypertension treatment - Contribution of treprostinil dry-powder formulation
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Historical evolution from OPCAB to MIDCAB to mini OPCAB surgical technique and results
Federico Benetti, Benetti Foundation, Argentina
Title : Personalized and Precision Medicine (PPM) and PPN-guided cardiology practice as a unique model via translational applications and upgraded business modeling to secure human healthcare, wellness and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibodies with functionality as a new generation of translational tools designed to monitor autoimmune myocarditis at clinical and subclinical stages
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation